Download Free Sample Report

Psoriasis Treatment Drugs Market, Global Outlook and Forecast 2022-2028

Psoriasis Treatment Drugs Market, Global Outlook and Forecast 2022-2028

  • Published on : 06 October 2022
  • Pages :103
  • Report Code:SMR-7419060

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report contains market size and forecasts of Psoriasis Treatment Drugs in Global, including the following market information:
Global Psoriasis Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Psoriasis Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
TNF Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psoriasis Treatment Drugs include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psoriasis Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriasis Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
TNF Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Corticosteroids
Others
Global Psoriasis Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Oral
Parenteral
Topical
Global Psoriasis Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psoriasis Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Psoriasis Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer